WO2017047190A1 - 細胞判定方法、細胞判定装置及び細胞判定プログラム - Google Patents
細胞判定方法、細胞判定装置及び細胞判定プログラム Download PDFInfo
- Publication number
- WO2017047190A1 WO2017047190A1 PCT/JP2016/068549 JP2016068549W WO2017047190A1 WO 2017047190 A1 WO2017047190 A1 WO 2017047190A1 JP 2016068549 W JP2016068549 W JP 2016068549W WO 2017047190 A1 WO2017047190 A1 WO 2017047190A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell
- optical path
- path length
- cells
- determination
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 35
- 230000003287 optical effect Effects 0.000 claims abstract description 167
- 229920002527 Glycogen Polymers 0.000 claims abstract description 68
- 229940096919 glycogen Drugs 0.000 claims abstract description 68
- 230000003834 intracellular effect Effects 0.000 claims abstract description 26
- 210000004027 cell Anatomy 0.000 claims description 289
- 210000001778 pluripotent stem cell Anatomy 0.000 claims description 38
- 238000001000 micrograph Methods 0.000 claims description 20
- 238000005259 measurement Methods 0.000 claims description 11
- 230000002596 correlated effect Effects 0.000 claims description 9
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims description 7
- 238000010186 staining Methods 0.000 description 19
- 239000002609 medium Substances 0.000 description 16
- 230000004069 differentiation Effects 0.000 description 11
- 210000005229 liver cell Anatomy 0.000 description 11
- 210000000130 stem cell Anatomy 0.000 description 10
- 230000000007 visual effect Effects 0.000 description 9
- 238000004113 cell culture Methods 0.000 description 8
- 238000003384 imaging method Methods 0.000 description 8
- 210000004413 cardiac myocyte Anatomy 0.000 description 7
- 238000001069 Raman spectroscopy Methods 0.000 description 6
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 229930002330 retinoic acid Natural products 0.000 description 6
- 229960001727 tretinoin Drugs 0.000 description 6
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 5
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 5
- 230000010287 polarization Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 230000007423 decrease Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 210000002569 neuron Anatomy 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 210000001130 astrocyte Anatomy 0.000 description 3
- 230000032823 cell division Effects 0.000 description 3
- 238000000701 chemical imaging Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000012744 immunostaining Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- 239000013307 optical fiber Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 230000010627 oxidative phosphorylation Effects 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 210000001082 somatic cell Anatomy 0.000 description 2
- 238000009331 sowing Methods 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003667 anti-reflective effect Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 238000009126 molecular therapy Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/41—Refractivity; Phase-affecting properties, e.g. optical path length
- G01N21/45—Refractivity; Phase-affecting properties, e.g. optical path length using interferometric methods; using Schlieren methods
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/34—Measuring or testing with condition measuring or sensing means, e.g. colony counters
- C12M1/3446—Photometry, spectroscopy, laser technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/30—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
- C12M41/38—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of metabolites or enzymes in the cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1429—Signal processing
- G01N15/1433—Signal processing using image recognition
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1434—Optical arrangements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1468—Optical investigation techniques, e.g. flow cytometry with spatial resolution of the texture or inner structure of the particle
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/41—Refractivity; Phase-affecting properties, e.g. optical path length
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
- G02B21/36—Microscopes arranged for photographic purposes or projection purposes or digital imaging or video purposes including associated control and data processing arrangements
- G02B21/361—Optical details, e.g. image relay to the camera or image sensor
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
- G02B21/36—Microscopes arranged for photographic purposes or projection purposes or digital imaging or video purposes including associated control and data processing arrangements
- G02B21/365—Control or image processing arrangements for digital or video microscopes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1006—Investigating individual particles for cytology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1434—Optical arrangements
- G01N2015/1454—Optical arrangements using phase shift or interference, e.g. for improving contrast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/063—Illuminating optical parts
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
Definitions
- the present invention relates to a cell determination method, a cell determination apparatus, and a cell determination program.
- Stem cells such as human-derived embryonic stem cells (ES cells) and induced pluripotent stem cells (iPS cells) have the ability to differentiate into many types of cells (pluripotency). Application to is expected.
- the differentiation efficiency in inducing differentiation from a stem cell to a target cell greatly depends on the state of the stem cell as a starting material. That is, if stem cells maintain pluripotency and do not maintain an undifferentiated state, the efficiency of differentiation induction decreases. Therefore, in order to industrially apply these stem cells, it is extremely important to manage the quality of the stem cells, and it is necessary to monitor the stem cells and determine the state non-invasively.
- ES cells are known to produce adenosine triphosphate (ATP) anaerobically using the glycolytic system in an undifferentiated state. Further, when differentiated, ATP supply mainly by oxidative phosphorylation using a citric acid circuit (TCA circuit) becomes dominant (Non-patent Document 1). ES cells are known to have higher glucose requirement than differentiated cells and contain glycogen in the cytoplasm (Non-patent Document 2).
- TCA circuit citric acid circuit
- Non-Patent Document 2 As a method for detecting glycogen, classic histochemical staining (PAS staining: Periodic acid Schiff stain) is known (for example, Non-Patent Document 2).
- Non-patent document 3 reports that glycogen in the cytoplasm of ES cells was quantified by Raman spectroscopic imaging.
- the PAS staining method requires non-invasive observation because it requires cell staining.
- Raman spectroscopic imaging described in Non-Patent Document 3 observation is possible without staining cells.
- the intensity of illumination light necessary for observation is also strong, and there is a possibility of damaging cells.
- Raman spectroscopic imaging it is difficult to separate Raman scattered light specific to cells from Raman scattered light derived from various components in the medium, and the cells in the medium cannot be observed as they are.
- the present invention has been made in view of these problems.
- a cell determination method and a cell determination apparatus capable of easily and non-invasively determining a cell type based on the content of glycogen in a cell. And it aims at providing a cell determination program.
- the present invention is a cell determination method for determining a cell type based on the content of glycogen in a cell, measuring an optical path length of a cell and acquiring optical path length data, and the obtained optical path length data From the calculation step for calculating the optical path length index correlating with the optical path length of the cell, the comparison step for comparing the calculated optical path length index with the threshold value, and based on the comparison result, the cell has a high content of glycogen in the cell. And a determination step of determining that the cell type is a cell type having a low intracellular glycogen content.
- the cell determination method of the present invention is based on the finding that the greater the glycogen content in a cell, the longer the optical path length.
- optical path length has the same meaning as “phase difference” or “optical thickness”.
- the cell type can be determined non-invasively and simply based on the content of glycogen in the cell. Moreover, since the optical path length is used as an index, cells in the medium can be determined as they are.
- the acquisition step may be a step of measuring optical path length from a quantitative phase microscope image of a cell and acquiring optical path length data.
- the cell determination method of the present invention further includes a measurement step of capturing an interference reflection microscope image of the cell and measuring the area of the colony from the interference reflection microscope image.
- the optical path length data of the cells included in the colony A value obtained by dividing the total value by the area of the colony may be calculated as an optical path length index.
- the cell type having a high glycogen content in the cell is a pluripotent stem cell
- the cell type having a low glycogen content in the cell is a differentiated pluripotent stem cell and cultured. It may be used for discriminating undifferentiated pluripotent stem cells from a cell population of pluripotent stem cells, or discriminating differentiated pluripotent stem cells.
- the cell determination method of the present invention for example, in subculture of pluripotent stem cells, discriminates undifferentiated pluripotent stem cells from a cell population of cultured pluripotent stem cells, or differentiated pluripotency It can be used to discriminate stem cells.
- iPS cells undifferentiated induced pluripotent stem cells
- differentiated iPS cells do not have such accumulation. Therefore, undifferentiated iPS cells and differentiated iPS cells can be determined by the cell determination method of the present invention.
- the pluripotent stem cell may be an induced pluripotent stem cell.
- the present invention also provides an acquisition means for acquiring optical path length data of a cell, a calculation means for calculating an optical path length index correlated with the optical path length of the cell from the acquired optical path length data, and the calculated optical path length index as a threshold value. Comparing means for comparing, and determining means for determining that a cell is a cell type having a high intracellular glycogen content or a cell type having a low intracellular glycogen content based on the comparison result.
- a cell determination device is provided.
- the cell determination apparatus may further include a second acquisition unit that acquires an interference reflection microscope image of a cell or data obtained by binarizing the image. By further providing the second acquisition means, the determination in units of colonies can be performed more easily.
- the present invention provides a computer, an acquisition means for acquiring optical path length data of a cell, a calculation means for calculating an optical path length index correlated with the optical path length of a cell from the acquired optical path length data, and the calculated optical path length index as a threshold value.
- the cell Based on the comparison result, based on the comparison result, the cell functions as a cell type having a high content of glycogen in the cell or a determination means for determining that the cell type is a cell type having a low content of glycogen in the cell.
- a cell determination program is provided.
- the cell determination program may include causing the computer to further function as a second acquisition unit that acquires an interference reflection microscope image of a cell or data obtained by binarizing the image.
- the cell determination program may be provided as a computer-readable recording medium on which the cell determination program is recorded.
- the cell type can be easily and non-invasively determined based on the content of glycogen in the cell.
- (A) It is a photograph which shows the result of having observed with time the quantitative phase microscope how a iPS cell divides.
- (B) It is the figure which highlighted and displayed the high brightness
- (A) A photograph showing the result of PAS staining of an iPS cell colony.
- (B) It is a photograph which shows the result of having observed the colony of the iPS cell with the quantitative phase microscope.
- (B) It is a photograph which shows the result of having carried out the alkaline phosphatase dyeing
- (B) It is a graph which shows the optical path length per unit area (average optical thickness of a colony) of each colony shown in FIG. It is a graph which shows the optical path length of an undifferentiated iPS cell and differentiation-induced iPS cell. It is a graph which shows the optical path length of an iPS cell-derived liver cell (differentiation early stage) and a mature liver cell.
- the present invention is based on obtaining a novel finding that there is a correlation between the optical path length (brightness) of a cell observed with a quantitative phase microscope and the content of glycogen in the cell. First, this new knowledge will be described.
- FIG. 1 (A) is a photograph showing the results of observing with time a quantitative phase microscope how iPS cells divide. Photos were taken every 20 minutes.
- FIG. 1B highlights an area with high brightness (high optical path length area) in the photograph of FIG.
- the nucleolus disappears with cell division (00:20), the high optical path length region present in the cytoplasm aggregates (00:40), and is divided into two (04:00) , Distributed to two cells (05:00).
- this high optical path length region always appears at the time of cell division.
- one or two high optical path length regions appear in the cell as an endoplasmic reticulum-like structure as it accompanies the dyed yarn.
- FIG. 2 (A) is a photograph showing the result of PAS staining of a colony of iPS cells.
- FIG. 2 (B) is a photograph showing the results of observing iPS cell colonies with a quantitative phase microscope.
- FIGS. 2 (A) and (B) cells in the division phase are circled.
- the same position as the above-mentioned high optical path length region is stained with PAS staining. Further, since the high optical path length region disappears by amylase treatment (not shown), it is estimated that glycogen is accumulated in the high optical path length region.
- FIG. 3 (A) is a photograph showing the result of PAS staining of an iPS cell colony.
- FIG. 3 (B) is a photograph showing the result of alkaline phosphatase staining (AP staining) of the same colony as in FIG. 3 (A).
- AP staining undifferentiated iPS cells are stained.
- 3A and 3B differentiated cells not stained with AP (middle portion) are similarly not stained with PAS staining, and undifferentiated iPS cells stained with AP are stained with PAS staining.
- the optical path length (brightness) observed with the quantitative phase microscope is obtained by multiplying “the actual thickness of the cell” by “the refractive index difference between the cell and the medium”. It is considered that the actual thickness of the cells and the refractive index of the culture medium and the cells are not significantly different. Therefore, it is considered that a slight change in the optical path length is observed when a slight difference in refractive index occurs. Since the refractive index of glycogen is 1.69, which is higher than the refractive index (1 to 1.5) of general biopolymers, the length of the optical path length (high luminance) increases when the accumulation amount (content) is large. It is thought that a large change is observed in (a).
- the cell determination method of the present invention is to determine a cell type based on the content of glycogen in the cell.
- Cell type to be judged Since the cell determination method of the present embodiment performs determination based on glycogen content, cell types having a high glycogen content and cell types having a low glycogen content may be mixed or mixed. Can be used to determine cell types with high glycogen content and / or cell types with low glycogen content.
- Examples of cell types having a high glycogen content and cell types having a low glycogen content include a high glycogen content such as a cell type that produces ATP, which is an energy source of cells, mainly using an anaerobic thawing system.
- Examples include cell types with low glycogen content, such as cell types that produce ATP, which is an energy source of cells, mainly using oxidative phosphorylation in the TCA cycle.
- mixed cell lines include, but are not limited to, pluripotent stem cell culture systems (culture systems aimed at maintaining pluripotency), pluripotent stem cells as liver, kidney, heart , Cell culture system for differentiation into somatic cells such as pancreas and nerve, culture system of cells derived from cardiac muscle tissue, liver tissue and nerve tissue, mixed culture system of nerve cells / astroglia cells, and lymphocytes of leukemia patients Mention may be made of cell culture systems.
- the cell determination method of the present embodiment may be used to determine undifferentiated pluripotent stem cells from a cultured pluripotent stem cell population or to determine differentiated pluripotent stem cells. Thereby, quality control (maintenance of an undifferentiated state) of the subcultured cells can be easily performed non-invasively. Moreover, when differentiating pluripotent stem cells into somatic cells in regenerative medicine or the like, the differentiated pluripotent stem cells can be easily and non-invasively discriminated.
- fetal cardiomyocytes cells types with high glycogen content
- adult cardiomyocytes with low glycogen content
- the cell determination method of the present embodiment may be used to discriminate fetal cardiomyocytes from cultured cardiomyocyte cell populations or to discriminate adult cardiomyocytes. This is effective for quality evaluation of mature cardiomyocytes such as a myocardial sheet in regenerative medicine.
- the cell determination method of the present embodiment may be used to determine a nerve cell from a cultured cell population of neurons and astroglia cells, or to determine an astroglia cell.
- PAS staining is used for the classification and progression of leukemia (J. Clin. Pathol., 1979, Vol. 32, pp. 158-161). Therefore, the cell determination method of this embodiment may be used for classification of leukemia or determination of progression.
- the acquisition step is a step of measuring the optical path length of the cell and acquiring optical path length data.
- the optical path length data of the cell can be obtained as “phase difference” or “optical thickness” by imaging the cell with a quantitative phase microscope or phase contrast microscope, for example.
- the optical path length data may be acquired for a single cell or may be acquired for a plurality of cells (for example, a cell colony unit or a microscope visual field unit).
- the target cell is usually a cultured cell.
- the optical path length data of the cells in the culture medium may be measured to acquire optical path length data because the medium components are less susceptible to the determination result. Since the cells in the culture medium can be measured, the operation becomes extremely simple.
- the calculating step is a step of calculating an optical path length index correlated with the optical path length of the cell from the optical path length data obtained in the obtaining step.
- the optical path length index correlates with the optical path length of the cell. That is, as long as the correlation between the optical path length of the cell and the glycogen content in the cell can be used for determination, the optical path length index may be, for example, the acquired optical path length data as it is, It may be an index (for example, an average value) calculated based on optical path length data acquired for cells.
- the optical path length index may be, for example, a value obtained by dividing the total value of the optical path length data acquired for a cell population included in a certain colony by the area of the colony (the optical path length per unit area of a certain colony).
- the area of a colony is measured by taking an interference reflection microscope (IRM) image and binarizing the IRM image to distinguish between a culture substrate to which cells are adhered and a culture substrate to which cells are not adhered. Can do.
- IRM interference reflection microscope
- the optical path length index may also be a value obtained by dividing the total value of optical path length data acquired for a cell population included in one visual field of a microscope by the area of the cell population included in the visual field (per unit cell area in a visual field). The optical path length).
- the comparison step is a step of comparing the optical path length index calculated in the calculation step with a threshold value.
- the threshold value can be appropriately set according to the cell type to be determined, the culture conditions, and the like. For example, when an undifferentiated pluripotent stem cell or a differentiated pluripotent stem cell is a determination target in the pluripotent stem cell culture system, the above-described acquisition step and calculation step are performed in the pluripotent stem cell culture system. Then, an optical path length index is calculated.
- undifferentiated pluripotent stem cells and differentiated pluripotent stem cells are discriminated in accordance with a conventional method (for example, AP staining, anti-Nanog antibody staining). Based on these results, a threshold that can distinguish undifferentiated pluripotent stem cells and differentiated pluripotent stem cells is set in advance.
- the determination step is a step for determining that the cell is a cell type having a high intracellular glycogen content or a cell type having a low intracellular glycogen content based on the result of comparison in the comparison step.
- the determination is made as follows. (I) if the optical path length index is greater than or equal to the threshold, the cell is determined to be a cell type with a high intracellular glycogen content; or (ii) if the optical path length index is less than the threshold, the cell is It is determined that the cell type has a low glycogen content.
- the determination is made as follows. (Iii) If the optical path length index exceeds a threshold value, the cell is determined to be a cell type having a low intracellular glycogen content, or (iv) if the optical path length index is less than or equal to the threshold value, the cell is an intracellular glycogen. It is determined that the cell type has a high content.
- the cell determination device is used as a cytometer in combination with an optical path length measurement device.
- an optical path length measuring device for example, a quantitative phase microscope or a phase contrast microscope can be used.
- FIG. 4 is a configuration diagram of a cytometer according to an embodiment.
- the cytometer 1 shown in FIG. 4 is mainly configured by a microscope system A and a cell determination device D that combine an optical system of an interference reflection microscope and an optical system of a quantitative phase microscope.
- the microscope system A may be configured only by an optical system of a quantitative phase microscope.
- the microscope system A further includes the optical system of the interference reflection microscope, the area of a single cell, the area of a colony, and the area of a cell in a visual field can be measured together.
- the optical system of the quantitative phase microscope includes a lens A2 facing an emission side end face B1 of an optical fiber B that guides irradiation light H0 (laser light) from a light emission unit (not shown) on the light incident side, and the lens A2 A reflecting portion A3 that reflects the transmitted irradiation light H0 is provided.
- an imaging device C such as a CCD camera is provided that images an interference fringe (not shown, the same applies hereinafter) generated by the optical interference unit A7. It is done.
- the microscope A includes a microscope main body A1 including at least a sample stage A4 that supports the measurement sample S, an objective lens A5, a reflection part A6, and a light interference part A7. As shown in FIG. 4, the microscope main body A1 may further include an optical system A8 of an interference reflection microscope.
- the sample stage A4 has, for example, a substantially plate shape having a light transmission part A41 capable of transmitting light at the center and a placement surface A42 on which the measurement sample S can be placed on the upward surface.
- a light transmission part A41 capable of transmitting light at the center
- a placement surface A42 on which the measurement sample S can be placed on the upward surface.
- the light transmitting portion A41 may be formed from a member that can transmit light, such as glass, or may be a simple hole.
- the objective lens A5 for example, expands incident measurement light H1 at a predetermined magnification according to the operation and emits it as parallel light based on an operation of an operation unit (not shown).
- the reflection part A6 is, for example, a total reflection type mirror, and allows the light to be measured H1 from the objective lens A5 to be totally reflected and introduced into the light interference part A7.
- the optical interference unit A7 splits the light to be measured H1 into two lights H1a and H1b, and the light to be measured H1 (H1a and H1b) emitted from the light separation element A71 is converged light H2 (H2a). , H2b), a converging lens A72, a spatial filter A73 disposed at the convergence position of the convergent light H2, an object fringe passing through the spatial filter A73 and the reference light H4 are superimposed to generate an interference fringe. And a lens A75.
- the light separating element A71 is configured using a diffraction grating. Furthermore, the light separation element A71 may be a polarization separation element that separates two light beams having different polarization directions. In that case, the optical interference unit A7 separates the measured light H1 into two light beams H1a and H1b having different polarization directions, and a condensing lens A72 that converts the light beam to be converged light H2 (H2a and H2b).
- the spatial filter A73 disposed at the convergence position of the convergent light H2, the object light H3 and the reference light H4 transmitted through the spatial filter A73, the half-wave plate A74 disposed on the emission side of the spatial filter A73, and the half-wave plate And a combining lens A75 that generates interference fringes by superimposing the object light H3 and the reference light H4 whose polarization directions are aligned by A74.
- a polarizer may be disposed to align the polarization directions of the object light H3 and the reference light H4.
- the optical system A8 of the interference reflection microscope measures light reflected by the measurement sample S (measurement light H1) by irradiating light from below with the measurement sample S placed on the placement surface A42.
- the optical system of the interference reflection microscope has a band-pass filter A84 and an aperture slit A83 facing an emission side end face B3 of an optical fiber B2 that guides irradiation light (laser light) from a light source (not shown) to the light incident side.
- a reflection part A81 for example, a beam splitter
- the light source is composed of a white LED or the like.
- a reflecting portion A82 (for example, a dichroic mirror) that reflects the measured light H1 from the objective lens 5 and the reflecting portion A81 and guides it to the condenser lens A85.
- An imaging device C1 such as a CCD camera, is provided that images the light to be measured converged by the condenser lens A85 and forms an image.
- FIG. 5 is a schematic diagram illustrating a hardware configuration of the cell determination device D according to the embodiment
- FIG. 6 is a schematic diagram illustrating a functional configuration of the cell determination device D according to the embodiment.
- the cell determination device D is physically a main storage device such as a CPU D11, ROM D12 and RAM D13, an input device D14 such as a keyboard and a mouse, an output device D15 such as a display, for example, imaging.
- the computer is configured as a normal computer including a communication module D16 such as a network card for transmitting and receiving data to and from other devices such as the device C, an auxiliary storage device D17 such as a hard disk, and the like.
- Each function of the cell determination apparatus D to be described later is to read predetermined computer software on hardware such as CPU D11, ROM D12, RAM D13, etc., thereby controlling input device D14, output device D15, This is realized by operating the communication module D16 and reading and writing data in the main storage devices D12 and D13 and the auxiliary storage device D17.
- the cell determination apparatus D includes an acquisition unit D1, a calculation unit D2, a comparison unit D3, a determination unit D4, and a display unit D5 as functional components.
- the acquisition means D1 acquires optical path length data from a quantitative phase microscope image taken by the imaging device C.
- the acquisition unit D1 also functions as a unit that acquires interference reflection microscope image data captured by the imaging device C1 or data obtained by binarizing the interference reflection microscope image data.
- the calculating means D2 calculates the above-mentioned optical path length index from the acquired optical path length data.
- the comparison unit D3 compares the calculated optical path length index with a threshold value. As the threshold value, one stored in advance in the auxiliary storage device D17 or the like of the cell determination device D may be read.
- the determination means D4 determines the cell type based on the comparison result.
- the display means D5 displays the determined result.
- the cell determination program causes the computer to function as the acquisition unit D1, the calculation unit D2, the comparison unit D3, the determination unit D4, and the display unit D5 described above. By causing the computer to read the cell determination program, the computer operates as the cell determination device D.
- the cell determination program is provided by being recorded on a computer-readable recording medium, for example.
- the recording medium may be a non-temporary recording medium. Examples of the recording medium include a recording medium such as a flexible disk, a CD, and a DVD, a recording medium such as a ROM, and a semiconductor memory.
- FIG. 7 is a flowchart of the cell determination method. Using the cell determination method performed by the cell determination apparatus D, it is determined whether the target cell is a cell type having a high intracellular glycogen content or a cell type having a low intracellular glycogen content. And automatically with high accuracy.
- the acquisition unit D1 acquires optical path length data of cells from the imaging device C.
- the optical path length index is, for example, the optical path length per unit area of a certain colony, or the optical path length per unit cell area in a visual field
- the colony or the IRM image of the visual field from which the optical path length data is acquired is You may acquire by the acquisition means D1.
- an optical path length index is calculated from the optical path length data acquired by the calculating means D2.
- the optical path length index is, for example, an optical path length per unit area of a certain colony, or an optical path length per unit cell area in a certain visual field, cells from the IRM image of the colony or visual field from which optical path length data has been acquired It may include calculating an area (eg, a colony area).
- the comparison unit D3 compares the optical path length index calculated in the calculation step S2 with the threshold value, and extracts the result.
- the comparison unit D3 may include reading a threshold value stored in advance in the auxiliary storage device D17 or the like.
- the determination unit D4 is a cell type having a high intracellular glycogen content or a cell type having a low intracellular glycogen content. Determine if there is.
- the determination unit D4 determines as follows based on the comparison result in the comparison step S3.
- the optical path length index is an index positively correlated with the optical path length of the cell (when the optical path length index increases as the optical path length of the cell increases); (I) if the optical path length index is greater than or equal to the threshold, the cell is determined to be a cell type with a high intracellular glycogen content; or (ii) if the optical path length index is less than the threshold, the cell is It is determined that the cell type has a low glycogen content.
- the optical path length index is an index negatively correlated with the optical path length of the cell (when the optical path length index decreases as the optical path length of the cell increases); (Iii) If the optical path length index exceeds a threshold value, the cell is determined to be a cell type having a low intracellular glycogen content, or (iv) if the optical path length index is less than or equal to the threshold value, the cell is an intracellular glycogen. It is determined that the cell type has a high content.
- the display means D5 displays the result determined in determination step S4. For example, the display unit D5 displays whether the cell is a cell type having a high intracellular glycogen content or a cell type having a low intracellular glycogen content.
- differentiated cells and undifferentiated iPS cells are determined in the subculture of iPS cells by the cell determination method of the present invention.
- this invention is not limited to the example shown below.
- FIG. 8 is a photograph showing an example of determining differentiated cells and undifferentiated iPS cells in subculture of iPS cells (253G1 strain).
- FIG. 8A is a quantitative phase microscopic image of a colony formed by culturing for 3 days after passage. A single field of view contains multiple colonies. The higher the brightness (the longer the optical path length), the more white the image is displayed.
- FIG. 8 (B) is a fluorescence microscopic image obtained by immunostaining the same colony as in FIG. 8 (A) with an anti-Nanog antibody. Colonies stained with the immunostaining (fluorescence is observed) are undifferentiated iPS cells. Since the immunostaining is not quantitative, it does not coincide with the luminance in FIG.
- FIG. 8A the colony having a high luminance (long optical path length) in FIG. 8A is immunostained with an anti-Nanog antibody.
- the optical path length (luminance) observed with the quantitative phase microscope exceeds a predetermined value, it can be determined that the cell is an undifferentiated iPS cell or colony.
- FIG. 9A is a graph showing the area of each colony shown in FIG.
- the area of each colony was calculated by binarizing an IRM image separately captured by an interference reflection microscope by image processing to distinguish between a culture substrate to which cells are adhered and a culture substrate to which cells are not adhered.
- the horizontal axis is the culture time. It can be seen that the colony area increases as the culture time increases.
- FIG. 9B is a graph showing the optical path length (average colony optical thickness: nm / mm 2 ) per unit area of each colony shown in FIG.
- FIG. 10 is a graph showing the optical path lengths of undifferentiated iPS cells and differentiated iPS cells.
- FIG. 11 is a graph showing optical path lengths of iPS cell-derived young liver cells and mature liver cells. The optical path lengths shown in FIGS. 10 and 11 indicate the luminance (optical path length) extracted from the quantitative phase microscope image.
- IPS cells and “iPS cells (retinoic acid-induced)” shown in FIG. 10 and “iPS-derived liver cells” and “primary liver cells” shown in FIG. 11 were cultured as follows.
- IPS cells are anti-reflective coated plastic bottom dishes coated with a Matrigel (registered trademark) basement membrane matrix (manufactured by Becton Dickinson, hereinafter also referred to as “substrate”) to human living fibroblasts.
- the derived iPS cell line (253G1 strain) is seeded at 10 to 20 colonies / dish, and a synthetic medium for pluripotent stem cell culture (mTeSR (registered trademark) 1, manufactured by StemCell, hereinafter also referred to as “synthetic medium”).
- mTeSR pluripotent stem cell culture
- the size of one colony was about 200 ⁇ m.
- Cells were cultured until 3 days after seeding.
- the synthetic medium was changed once a day. On the third day after sowing, a quantitative phase microscope image was taken and the optical path length was measured.
- IPS cells retinoic acid induction
- iPS cells retinoic acid induction
- IPS-derived liver cells are liver cells derived from “iPS cells” according to procedures described in non-patent literature (Molecular Therapy, 2011, Vol. 19, No. 2, pp. 400-407). On the 18th and 25th days after the start of induction, quantitative phase microscope images were taken and the optical path length was measured.
- Primary liver cells were cultured using Hepato-STIM medium (manufactured by Becton Dickinson) using BD Genest Human Hepatocyte (catalog number 454550, lot number 299) obtained from Becton Dickinson. On the first day after sowing, a quantitative phase microscope image was taken and the optical path length was measured.
- the optical path length is decreased by the addition of retinoic acid, which is known as a reagent for inducing differentiation, compared to “iPS cells” that are undifferentiated pluripotent stem cells.
- retinoic acid which is known as a reagent for inducing differentiation
- the optical path length decreases with differentiation induction. By maturation, the optical path length increases due to the accumulation of glycogen.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Multimedia (AREA)
- Optics & Photonics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Sustainable Development (AREA)
- Medicinal Chemistry (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Biophysics (AREA)
- Developmental Biology & Embryology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Signal Processing (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
本発明の細胞判定方法は、細胞内のグリコーゲンの含有量に基づいて細胞種を判定するものである。
本実施形態の細胞判定方法は、グリコーゲン含有量に基づく判定を行うものであるため、グリコーゲン含有量の多い細胞種とグリコーゲン含有量の少ない細胞種とが混在している、又は混在している可能性がある細胞系(まとめて「混在細胞系」という。)において、グリコーゲン含有量の多い細胞種、及び/又はグリコーゲン含有量の少ない細胞種を判定するために用いることができる。
取得ステップは、細胞の光路長を測定し、光路長データを取得するステップである。細胞の光路長データは、例えば、定量位相顕微鏡、位相差顕微鏡により細胞を撮像することで、「位相差」又は「光学厚さ」として得ることができる。光路長データは、単一細胞について取得してもよいし、複数の細胞(例えば、細胞コロニー単位、顕微鏡の視野単位)について取得してもよい。
算出ステップは、取得ステップで得られた光路長データから、細胞の光路長と相関する光路長指標を算出するステップである。光路長指標は、細胞の光路長と相関するものである。すなわち、細胞の光路長と細胞内のグリコーゲンの含有量との間の相関関係を判定に利用できる限りにおいて、光路長指標は、例えば、取得した光路長データそのままであってもよいし、複数の細胞について取得した光路長データに基づいて算出した指標(例えば、平均値)であってもよい。
比較ステップは、算出ステップで算出された光路長指標を閾値と比較するステップである。閾値は、判定対象とする細胞種、培養条件等に応じて適宜設定することができる。例えば、多能性幹細胞培養系で、未分化の多能性幹細胞、又は分化した多能性幹細胞を判定対象とする場合、多能性幹細胞培養系において、上述した取得ステップ、及び算出ステップを実施し、光路長指標を算出する。同じ多能性幹細胞培養系で、常法に従い(例えば、AP染色、抗Nanog抗体染色)、未分化の多能性幹細胞、及び分化した多能性幹細胞を判別する。これらの結果に基づき、未分化の多能性幹細胞、及び分化した多能性幹細胞を判別可能な閾値を予め設定する。
判定ステップは、比較ステップで比較した結果に基づき、細胞が細胞内のグリコーゲン含有量の多い細胞種である、又は細胞内のグリコーゲン含有量の少ない細胞種である、と判定するステップである。
(i)光路長指標が閾値以上である場合、細胞は細胞内のグリコーゲン含有量の多い細胞種であると判定する、又は
(ii)光路長指標が閾値未満である場合、細胞は細胞内のグリコーゲン含有量の少ない細胞種であると判定する。
(iii)光路長指標が閾値を超える場合、細胞は細胞内のグリコーゲン含有量の少ない細胞種であると判定する、又は
(iv)光路長指標が閾値以下である場合、細胞は細胞内のグリコーゲン含有量の多い細胞種であると判定する。
一実施形態において、細胞判定装置は、光路長測定装置と組み合わせてサイトメーターとして使用される。光路長測定装置としては、例えば、定量位相顕微鏡、位相差顕微鏡を使用できる。
定量位相顕微鏡の光学系は、光の入射側に、図示しない光出射部からの照射光H0(レーザ光)を導く光ファイバBの出射側端面B1に臨ませたレンズA2と、このレンズA2を透過する照射光H0を反射する反射部A3を具備する。一方、定量位相顕微鏡の光学系の光の出射側には、光干渉部A7で生成される干渉縞(図示せず、以下同様)を撮像して画像とするCCDカメラ等の撮像装置Cが設けられる。
干渉反射顕微鏡の光学系A8は、載置面A42に測定試料Sを載置した状態で下方から光を照射することにより、測定試料Sで反射した光(被測定光H1)を測定する。干渉反射顕微鏡の光学系は、光の入射側に、光源(図示せず)からの照射光(レーザ光)を導く光ファイバB2の出射側端面B3に臨ませたバンドパスフィルタA84及び開口スリットA83と、このバンドパスフィルタA84及び開口スリットA83を透過する照射光を反射する反射部A81(例えば、ビームスプリッタ)を具備する。光源は、白色LED等で構成される。一方、干渉反射顕微鏡の光学系の光の出射側には、対物レンズ5及び反射部A81からの被測定光H1を反射させて集光レンズA85に導く、反射部A82(例えば、ダイクロイックミラー)と、集光レンズA85で収束された被測定光を撮像して画像とするCCDカメラ等の撮像装置C1が設けられる。
細胞判定装置Dの構成について説明する。図5は、一実施形態に係る細胞判定装置Dのハードウェア的構成を示す概要図であり、図6は、一実施形態に係る細胞判定装置Dの機能的構成を示す概要図である。
細胞判定プログラムは、コンピュータを、上述した取得手段D1、算出手段D2、比較手段D3、判定手段D4、及び表示手段D5として機能させるものである。コンピュータに細胞判定プログラムを読み込ませることにより、コンピュータは細胞判定装置Dとして動作する。細胞判定プログラムは、例えば、コンピュータ読み取り可能な記録媒体に記録されて提供される。記録媒体は、非一時的記録媒体であってもよい。記録媒体としては、フレキシブルディスク、CD、DVD等の記録媒体、ROM等の記録媒体、半導体メモリ等が例示される。
細胞判定装置Dにより行われる細胞判定方法について説明する。図7は細胞判定方法のフローチャートである。細胞判定装置Dにより行われる細胞判定方法により、対象となる細胞が、細胞内のグリコーゲン含有量の多い細胞種であるか、又は細胞内のグリコーゲン含有量の少ない細胞種であるかの判定を定量的且つ自動的に精度高く行うことができる。
最初に、取得手段D1が撮像装置Cから細胞の光路長データを取得する。光路長指標が、例えば、あるコロニーの単位面積あたりの光路長である場合、又はある視野中の単位細胞面積あたりの光路長である場合、光路長データを取得したコロニー又は視野のIRM像は、取得手段D1により取得してもよい。
次に、算出手段D2が取得した光路長データから光路長指標を算出する。光路長指標が、例えば、あるコロニーの単位面積あたりの光路長である場合、又はある視野中の単位細胞面積あたりの光路長である場合、光路長データを取得したコロニー又は視野のIRM像から細胞面積(例えば、コロニー面積)を算出することを含んでもよい。
次に、比較手段D3が、算出ステップS2にて算出した光路長指標と閾値を比較し、その結果を抽出する。比較手段D3は、補助記憶装置D17等に予め格納されている閾値を読み出すことを含んでもよい。
次に、判定手段D4が、比較ステップS3にて抽出した比較の結果に基づき、細胞が、細胞内のグリコーゲン含有量の多い細胞種であるか、又は細胞内のグリコーゲン含有量の少ない細胞種であるかを判定する。判定手段D4は、比較ステップS3の比較の結果に基づいて、以下のように判定する。
光路長指標が、細胞の光路長と正に相関する指標である場合(細胞の光路長が長くなると光路長指標が大きくなる場合);
(i)光路長指標が閾値以上である場合、細胞は細胞内のグリコーゲン含有量の多い細胞種であると判定する、又は
(ii)光路長指標が閾値未満である場合、細胞は細胞内のグリコーゲン含有量の少ない細胞種であると判定する。
光路長指標が、細胞の光路長と負に相関する指標である場合(細胞の光路長が長くなると光路長指標が小さくなる場合);
(iii)光路長指標が閾値を超える場合、細胞は細胞内のグリコーゲン含有量の少ない細胞種であると判定する、又は
(iv)光路長指標が閾値以下である場合、細胞は細胞内のグリコーゲン含有量の多い細胞種であると判定する。
次に、表示手段D5が、判定ステップS4にて判定した結果を表示する。例えば、細胞が、細胞内のグリコーゲン含有量の多い細胞種であるか、又は細胞内のグリコーゲン含有量の少ない細胞種であるかが表示手段D5によって表示される。
Claims (10)
- 細胞内のグリコーゲンの含有量に基づいて細胞種を判定する細胞判定方法であって、
細胞の光路長を測定し、光路長データを取得する取得ステップと、
得られた光路長データから、細胞の光路長と相関する光路長指標を算出する算出ステップと、
算出された光路長指標を閾値と比較する比較ステップと、
比較した結果に基づき、細胞が細胞内のグリコーゲン含有量の多い細胞種である、又は細胞内のグリコーゲン含有量の少ない細胞種である、と判定する判定ステップと、
を備える、細胞判定方法。 - 前記取得ステップは、細胞の定量位相顕微鏡像から光路長を測定し、光路長データを取得するステップである、請求項1に記載の細胞判定方法。
- 細胞の干渉反射顕微鏡像を撮像し、当該干渉反射顕微鏡像からコロニーの面積を測定する測定ステップを更に備え、
前記算出ステップでは、コロニーに含まれる細胞の光路長データの合計値を当該コロニーの面積で除した値を光路長指標として算出する、請求項1又は2に記載の細胞判定方法。 - 前記細胞内のグリコーゲン含有量の多い細胞種が、多能性幹細胞であり、前記細胞内のグリコーゲン含有量の少ない細胞種が、分化した多能性幹細胞であり、
培養された多能性幹細胞の細胞集団から未分化の多能性幹細胞を判別する、又は分化した多能性幹細胞を判別するために用いられる、請求項1~3のいずれか一項に記載の細胞判定方法。 - 前記多能性幹細胞が、人工多能性幹細胞である、請求項4に記載の細胞判定方法。
- 細胞の光路長データを取得する取得手段と、
取得した光路長データから、細胞の光路長と相関する光路長指標を算出する算出手段と、
算出した光路長指標を閾値と比較する比較手段と、
比較した結果に基づき、細胞が細胞内のグリコーゲン含有量の多い細胞種である、又は細胞内のグリコーゲン含有量の少ない細胞種である、と判定する判定手段と、
を備える、細胞判定装置。 - 細胞の干渉反射顕微鏡像又はこれを二値化したデータを取得する第2の取得手段を更に備える、請求項6に記載の細胞判定装置。
- コンピュータを、
細胞の光路長データを取得する取得手段、
取得した光路長データから、細胞の光路長と相関する光路長指標を算出する算出手段、
算出した光路長指標を閾値と比較する比較手段、
比較した結果に基づき、細胞が細胞内のグリコーゲン含有量の多い細胞種である、又は細胞内のグリコーゲン含有量の少ない細胞種である、と判定する判定手段、
として機能させるための細胞判定プログラム。 - 前記コンピュータを、細胞の干渉反射顕微鏡像又はこれを二値化したデータを取得する第2の取得手段として更に機能させることを含む、請求項8に記載の細胞判定プログラム。
- 請求項8又は9に記載の細胞判定プログラムが記録されたコンピュータ読み取り可能な記録媒体。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201680053584.6A CN108026563B (zh) | 2015-09-16 | 2016-06-22 | 细胞判定方法、细胞判定装置及细胞判定程序 |
GB1806053.3A GB2560452B (en) | 2015-09-16 | 2016-06-22 | Cell determination method, cell determination device and cell determination program |
DE112016004209.4T DE112016004209T5 (de) | 2015-09-16 | 2016-06-22 | Zellenbestimmungsverfahren, Zellenbestimmungsvorrichtung und Zellenbestimmungsprogramm |
US15/760,348 US10570435B2 (en) | 2015-09-16 | 2016-06-22 | Cell determination method, cell determination device and cell determination program |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015183067A JP6518173B2 (ja) | 2015-09-16 | 2015-09-16 | 細胞判定方法、細胞判定装置及び細胞判定プログラム |
JP2015-183067 | 2015-09-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017047190A1 true WO2017047190A1 (ja) | 2017-03-23 |
Family
ID=58288721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2016/068549 WO2017047190A1 (ja) | 2015-09-16 | 2016-06-22 | 細胞判定方法、細胞判定装置及び細胞判定プログラム |
Country Status (6)
Country | Link |
---|---|
US (1) | US10570435B2 (ja) |
JP (1) | JP6518173B2 (ja) |
CN (1) | CN108026563B (ja) |
DE (1) | DE112016004209T5 (ja) |
GB (1) | GB2560452B (ja) |
WO (1) | WO2017047190A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019013191A (ja) * | 2017-07-07 | 2019-01-31 | オリンパス株式会社 | 培養細胞解析システム、培養細胞解析方法、及び、プログラム |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6873390B2 (ja) * | 2017-03-02 | 2021-05-19 | 株式会社島津製作所 | 細胞解析方法及び細胞解析装置 |
JP7096054B2 (ja) * | 2018-04-13 | 2022-07-05 | 浜松ホトニクス株式会社 | 幹細胞が目的細胞に分化したか否かを判定する方法、分化判定装置、及び分化判定プログラム |
JP2020094925A (ja) * | 2018-12-13 | 2020-06-18 | 住友電気工業株式会社 | 品質評価方法 |
CN114418994B (zh) * | 2022-01-19 | 2022-11-15 | 生态环境部长江流域生态环境监督管理局生态环境监测与科学研究中心 | 一种基于显微镜图像的脆杆群体藻类细胞统计方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012147403A1 (ja) * | 2011-04-28 | 2012-11-01 | 浜松ホトニクス株式会社 | 細胞解析方法、細胞解析装置、および細胞解析プログラム |
JP2013249298A (ja) * | 2012-06-04 | 2013-12-12 | Infocom Corp | 抗がん剤の効果増強剤 |
JP2014039535A (ja) * | 2012-07-24 | 2014-03-06 | Univ Of Electro-Communications | 細胞識別装置及び細胞識別方法、並びに、細胞識別方法のプログラム及びそのプログラムを記録した記録媒体 |
WO2015076042A1 (ja) * | 2013-11-19 | 2015-05-28 | 国立大学法人京都大学 | 細胞判定方法、細胞判定装置及び細胞判定プログラム |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3228080B2 (ja) * | 1995-08-07 | 2001-11-12 | 富士電機株式会社 | 多重反射形試料セル |
US20040115683A1 (en) * | 2002-01-28 | 2004-06-17 | Medford June Iris | Analysis of gene expression and biological function using optical imaging |
US7952718B2 (en) * | 2007-05-03 | 2011-05-31 | University Of Washington | High resolution optical coherence tomography based imaging for intraluminal and interstitial use implemented with a reduced form factor |
US8412293B2 (en) * | 2007-07-16 | 2013-04-02 | Optiscan Biomedical Corporation | Systems and methods for determining physiological parameters using measured analyte values |
JP2015146747A (ja) * | 2014-02-05 | 2015-08-20 | 浜松ホトニクス株式会社 | 細胞判定方法 |
-
2015
- 2015-09-16 JP JP2015183067A patent/JP6518173B2/ja active Active
-
2016
- 2016-06-22 WO PCT/JP2016/068549 patent/WO2017047190A1/ja active Application Filing
- 2016-06-22 CN CN201680053584.6A patent/CN108026563B/zh active Active
- 2016-06-22 US US15/760,348 patent/US10570435B2/en active Active
- 2016-06-22 GB GB1806053.3A patent/GB2560452B/en active Active
- 2016-06-22 DE DE112016004209.4T patent/DE112016004209T5/de not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012147403A1 (ja) * | 2011-04-28 | 2012-11-01 | 浜松ホトニクス株式会社 | 細胞解析方法、細胞解析装置、および細胞解析プログラム |
JP2013249298A (ja) * | 2012-06-04 | 2013-12-12 | Infocom Corp | 抗がん剤の効果増強剤 |
JP2014039535A (ja) * | 2012-07-24 | 2014-03-06 | Univ Of Electro-Communications | 細胞識別装置及び細胞識別方法、並びに、細胞識別方法のプログラム及びそのプログラムを記録した記録媒体 |
WO2015076042A1 (ja) * | 2013-11-19 | 2015-05-28 | 国立大学法人京都大学 | 細胞判定方法、細胞判定装置及び細胞判定プログラム |
Non-Patent Citations (6)
Title |
---|
JOHKURA KOHEI ET AL.: "Cytochemical and ultrastructural characterization of growing colonies of human embryonic stem cells", JOURNAL OF ANATOMY, vol. 205, no. 4, October 2004 (2004-10-01), pages 247 - 255, XP055370464 * |
KIM JONGHWAN ET AL.: "Embryonic stem cell - specific signatures in cancer: insights into genomic regulatory networks and implications for medicine", GENOME MED., vol. 11, no. 75, March 2011 (2011-03-01), pages 1 - 8, XP055370449 * |
KONOROV STANISLAV O. ET AL.: "Absolute quantification of intracellular glycogen content in human embryonic stem cells with Raman microspectroscopy", ANAL.CHEM., vol. 83, no. 16, 15 August 2011 (2011-08-15), pages 6254 - 6258, XP055370466 * |
KONOROV STANISLAV O. ET AL.: "Raman microscopy- based cytochemical investigations of potential niche-forming inhomogeneities present in human embryonic stem cell colonies", APPL.SPECTROSC., vol. 65, no. 9, 1 September 2011 (2011-09-01), pages 1009 - 1016, XP055370471 * |
ROTHENBERG MICHAEL E. ET AL.: "The Myc connection: ES cells and cancer", CELL, vol. 143, no. 2, 2010, pages 184 - 186, XP028931127 * |
TOYOHIKO YAMAUCHI ET AL.: "Teiryo Iso Kenbikyo ni yoru Hito iPS Saibo no Hisenshoku Kansatsu", REGENERATIVE MEDICINE, vol. 15, 1 February 2016 (2016-02-01), pages 223 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019013191A (ja) * | 2017-07-07 | 2019-01-31 | オリンパス株式会社 | 培養細胞解析システム、培養細胞解析方法、及び、プログラム |
JP7079572B2 (ja) | 2017-07-07 | 2022-06-02 | オリンパス株式会社 | 培養細胞解析システム、培養細胞解析方法、及び、プログラム |
Also Published As
Publication number | Publication date |
---|---|
JP6518173B2 (ja) | 2019-05-22 |
CN108026563B (zh) | 2021-06-11 |
US20180265908A1 (en) | 2018-09-20 |
JP2017055699A (ja) | 2017-03-23 |
GB2560452B (en) | 2020-12-02 |
GB201806053D0 (en) | 2018-05-30 |
DE112016004209T5 (de) | 2018-06-07 |
CN108026563A (zh) | 2018-05-11 |
US10570435B2 (en) | 2020-02-25 |
GB2560452A (en) | 2018-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017047190A1 (ja) | 細胞判定方法、細胞判定装置及び細胞判定プログラム | |
Allier et al. | Imaging of dense cell cultures by multiwavelength lens‐free video microscopy | |
Sandoz et al. | Image-based analysis of living mammalian cells using label-free 3D refractive index maps reveals new organelle dynamics and dry mass flux | |
US11035845B2 (en) | Observation apparatus, observation method, observation system, program, and cell manufacturing method | |
Matov et al. | Analysis of microtubule dynamic instability using a plus-end growth marker | |
Kesavan et al. | High-throughput monitoring of major cell functions by means of lensfree video microscopy | |
Watanabe et al. | Limited predictive value of blastomere angle of division in trophectoderm and inner cell mass specification | |
Chan et al. | A rapid detection method for apoptosis and necrosis measurement using the Cellometer imaging cytometry | |
JP2015146747A (ja) | 細胞判定方法 | |
Di Iorio et al. | Q‐FIHC: Quantification of fluorescence immunohistochemistry to analyse p63 isoforms and cell cycle phases in human limbal stem cells | |
JP2012231709A (ja) | 細胞解析方法、細胞解析装置、および細胞解析プログラム | |
Nishimura et al. | Live-cell imaging of subcellular structures for quantitative evaluation of pluripotent stem cells | |
KR102166376B1 (ko) | 세포 판정 방법, 세포 판정 장치 및 세포 판정 프로그램 | |
Mann et al. | White light phase shifting interferometric microscopy with whole slide imaging for quantitative analysis of biological samples | |
WO2017090741A1 (ja) | 細胞塊に関する領域検出方法及び領域検出装置 | |
Meyer et al. | Optogenetic control of YAP reveals a dynamic communication code for stem cell fate and proliferation | |
Kawase et al. | Non-invasive, quantitative assessment of the morphology of γ-irradiated human mesenchymal stem cells and periosteal cells using digital holographic microscopy | |
JP2022049724A (ja) | 細胞種の推定方法、細胞種の推定装置、細胞の製造方法、細胞の製造装置、観察方法、観察装置、学習済モデルの製造方法、および学習済モデルの製造装置 | |
Kreutz et al. | Maximizing explanatory power in stereological data collection: A protocol for reliably integrating optical fractionator and multiple immunofluorescence techniques | |
JP6315655B2 (ja) | 細胞画像処理方法、細胞画像処理装置及び細胞画像処理プログラム | |
JP7096054B2 (ja) | 幹細胞が目的細胞に分化したか否かを判定する方法、分化判定装置、及び分化判定プログラム | |
Shankar et al. | Automated, High‐Throughput Phenotypic Screening and Analysis Platform to Study Pre‐and Post‐Implantation Morphogenesis in Stem Cell‐Derived Embryo‐Like Structures | |
Walther et al. | Automated live-cell single-molecule tracking in enteroid monolayers reveals transcription factor dynamics probing lineage-determining function | |
Eidhof et al. | Defined human PSC culture conditions robustly maintain human PSC pluripotency through Ca2+ signaling. | |
Durens et al. | High-content interrogation of human induced pluripotent stem cell-derived cortical organoid platforms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16846063 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15760348 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 112016004209 Country of ref document: DE |
|
ENP | Entry into the national phase |
Ref document number: 201806053 Country of ref document: GB Kind code of ref document: A Free format text: PCT FILING DATE = 20160622 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1806053.3 Country of ref document: GB |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16846063 Country of ref document: EP Kind code of ref document: A1 |